By Kunal Das July 15 (Reuters) – Shares of Celcuity fell nearly 19% in morning trading on Wednesday, as the delayed commercial launch of its newly approved breast cancer drug and label concerns
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Amazon AWS executive and CEO advisor Dave Brown to leave after 19 years
By Greg Bensinger SAN FRANCISCO, July 15 (Reuters) - Amazon veteran Dave Brown, a senior…
Regular sleep loss can lead to weight gain, health risks, study finds
Washington (dpa) - According to a new study published in the Annals of Internal Medicine,…
Robert Pattinson's 'The Batman Part II' gets another delay, will release in 2028
New Delhi [India], July 15 (ANI): The wait for Robert Pattinson's next Batman film just…
